Literature DB >> 21704035

Citrullination of autoantigens: upstream of TNFα in the pathogenesis of rheumatoid arthritis.

Anne-Marie Quirke1, Benjamin A C Fisher, Andrew J Kinloch, Patrick J Venables.   

Abstract

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterised by synovial inflammation and destruction of joints. Over 20 years ago, tumour necrosis factor alpha (TNFα) was identified as a key player in a cytokine network, whose multifunctional effects could account for both the inflammation and destruction in RA. The remarkable efficacy of TNF inhibitors in the treatment of RA has resulted in extensive research addressing the regulation of TNFα production responsible for this excessive production. The discovery of autoimmunity to citrullinated protein/peptide antigens (ACPA) has led the concept that ACPA may be the essential link between disease susceptibility factors and the production of TNFα, which ultimately accounts for the disease phenotype. In this review we will consider (1) the mechanisms of citrullination, both physiological and pathological, (2) how known genetic and environmental factors could drive this peculiar form of autoimmunity and (3) how the immune response could lead to excessive production of TNFα by the synovial cells and ultimately to the disease phenotype (Fig. 1).
Copyright © 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21704035     DOI: 10.1016/j.febslet.2011.06.006

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  19 in total

1.  Gilt required for RTL550-CYS-MOG to treat experimental autoimmune encephalomyelitis.

Authors:  Gregory G Burrows; Roberto Meza-Romero; Jianya Huan; Sushmita Sinha; Jeffrey L Mooney; Arthur A Vandenbark; Halina Offner
Journal:  Metab Brain Dis       Date:  2012-03-07       Impact factor: 3.584

2.  Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.

Authors:  Z Reyes-Castillo; C A Palafox-Sánchez; I Parra-Rojas; G E Martínez-Bonilla; S del Toro-Arreola; M G Ramírez-Dueñas; G Ocampo-Bermudes; José F Muñoz-Valle
Journal:  Clin Exp Immunol       Date:  2015-09-16       Impact factor: 4.330

Review 3.  The case for periodontitis in the pathogenesis of rheumatoid arthritis.

Authors:  Jan Potempa; Piotr Mydel; Joanna Koziel
Journal:  Nat Rev Rheumatol       Date:  2017-08-24       Impact factor: 20.543

4.  Incidence of inflammatory joint diseases in Finland: results from a population-based epidemiological study.

Authors:  A Kononoff; L Arstila; P Pussinen; H Kautiainen; P Elfving; E Savolainen; H Niinisalo; J Rutanen; O Marjoniemi; O Kaipiainen-Seppänen
Journal:  Rheumatol Int       Date:  2017-08-08       Impact factor: 2.631

Review 5.  The effect of targeted rheumatoid arthritis therapies on anti-citrullinated protein autoantibody levels and B cell responses.

Authors:  S Modi; M Soejima; M C Levesque
Journal:  Clin Exp Immunol       Date:  2013-07       Impact factor: 4.330

6.  Peptidylarginine deiminase 4 contributes to tumor necrosis factor α-induced inflammatory arthritis.

Authors:  Miriam A Shelef; Jeremy Sokolove; Lauren J Lahey; Catriona A Wagner; Eric K Sackmann; Thomas F Warner; Yanming Wang; David J Beebe; William H Robinson; Anna Huttenlocher
Journal:  Arthritis Rheumatol       Date:  2014-06       Impact factor: 10.995

7.  Anti-citrullinated protein antibodies activated ERK1/2 and JNK mitogen-activated protein kinases via binding to surface-expressed citrullinated GRP78 on mononuclear cells.

Authors:  Ming-Chi Lu; Ning-Sheng Lai; Wen-Yao Yin; Hui-Chun Yu; Hsien-Bin Huang; Chien-Hsueh Tung; Kuang-Yung Huang; Chia-Li Yu
Journal:  J Clin Immunol       Date:  2012-11-28       Impact factor: 8.317

Review 8.  The genetics of rheumatoid arthritis: risk and protection in different stages of the evolution of RA.

Authors:  Annie Yarwood; Tom W J Huizinga; Jane Worthington
Journal:  Rheumatology (Oxford)       Date:  2014-09-18       Impact factor: 7.580

9.  Synovial membrane protein expression differs between juvenile idiopathic arthritis subtypes in early disease.

Authors:  Sorcha Finnegan; Joanne Robson; Caitriona Scaife; Catherine McAllister; Stephen R Pennington; David S Gibson; Madeleine E Rooney
Journal:  Arthritis Res Ther       Date:  2014-01-13       Impact factor: 5.156

10.  Heightened immune response to autocitrullinated Porphyromonas gingivalis peptidylarginine deiminase: a potential mechanism for breaching immunologic tolerance in rheumatoid arthritis.

Authors:  Anne-Marie Quirke; Elena Birgitta Lugli; Natalia Wegner; Bart C Hamilton; Peter Charles; Muslima Chowdhury; A Jimmy Ytterberg; Roman A Zubarev; Jan Potempa; Shauna Culshaw; Yonghua Guo; Benjamin A Fisher; Geoffrey Thiele; Ted R Mikuls; Patrick Jw Venables
Journal:  Ann Rheum Dis       Date:  2013-03-05       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.